| | | | | |
YDES YD Bio Limited Ordinary Shares | €1,8521 | -1,63% | €244,38M | €53,27K | |
XCBE X3 Acquisition Corp. Ltd. Class A Ordinary Shares | €8,7132 | -0,30% | €244,07M | €13,25K | |
ALXO ALX Oncology Holdings Inc. Common Stock | €1,7602 | +2,03% | €243,92M | €667,28K | |
DUOT Duos Technologies Group, Inc. Common Stock | €7,3646 | -5,08% | €243,72M | €668,72K | |
AXIN Axiom Intelligence Acquisition Corp 1 Class A Ordinary Shares | €9,0766 | +0,34% | €243,54M | €8,16K | |
PMM Putnam Managed Municipal Income | €5,7358 | +1,08% | €243,05M | €47,87K | |
ADAG Adagene Inc. American Depositary Shares | €3,1613 | -5,50% | €242,43M | €197,40K | |
GLOO Gloo Holdings, Inc. Class A Common Stock | €2,9511 | +6,65% | €242,33M | €925,73K | |
NXDT NexPoint Diversified Real Estate Trust | €4,8952 | +4,49% | €242,32M | €301,39K | |
POWW Outdoor Holding Company Common Stock | €2,1017 | +0,84% | €242,10M | €518,92K | |
NAGE Niagen Bioscience, Inc. Common Stock | €2,8898 | -4,90% | €242,01M | €751,03K | |
SENS Senseonics Holdings, Inc. Common Stock | €4,4091 | -4,82% | €241,82M | €493,14K | |
OSG Octave Specialty Group, Inc. | €5,3593 | -0,16% | €241,63M | €243,70K | |
| €3,1613 | +7,12% | €240,76M | €97,19K | |
NHIV NewHold Investment Corp IV Class A Ordinary Shares | €8,8271 | +0,15% | €240,59M | €764,14K | |
